The Bulletin
The Times


.

Clarity commences Cu-64/Cu-67 SAR-bisPSMA theranostic prostate cancer trial

  • Written by PR Newswire

SYDNEY, July 28, 2021 /PRNewswire/ -- Clarity Pharmaceuticals, a clinical stage radiopharmaceutical company focused on the treatment of serious disease, is pleased to announce that it has commenced its 64/67Cu SAR-bisPSMA theranostic clinical trial in patients with metastatic castrate resistant prostate cancer (mCRPC) in the US. Patient...

The Bulletin Magazine

Pull Up Stands: A Convenient Display Option for Events and Promotions

How Mining Hose Selection Can Improve Material Transfer Systems

Electric Sliding Door: What to Consider Before Choosing One

What Is Included in a Professional Roof Repair Service on the Gold Coast?

The Unglamorous Baby Buys That Save Australian Parents the Most Time

Cryptocurrency Trading in 2026_ Why Regulated Education Is the New Standard

How Mining Hose Routing Can Influence Wear and Transfer Efficiency

Cryotherapy in Melbourne: What Skin Lesions Can Be Treated with Targeted Cold Therapy?

10 Restaurants in Cranbourne You Need to Try Before 2027

ZOLL Defibrillators: Why They're a Leading Choice for Businesses, Warehouses, and Healthcare Settings

How Property Maintenance Issues Can Affect Commercial Tenancies

Why All On 4 Dental Implants Are A Popular Full Smile Restoration Solution

hacklink hack forum hacklink film izle hacklink play Royal ReelsRoyal Reels pokiesRoyal Reels pokiesRoyal Reels loginBoss Rummycasinos not on gamstopnon gamstop casinos ukcasinos not on gamstopnon gamstop casinocasinos not on gamstoponline gamblingbest casinos not on gamstopgambling sites not on gamstopgambling sites not on gamstopPadişahbetcasibomRoyal reelsThe PokiesBetpipoBetpipoVipparkPadişahbetGalabetsafirbetimajbetcasibomcasinos not on gamstopnon uk casinosnot on gamstopcasinos not on gamstopcasinos non gamblock ukiptv satın aliptv satın alzlibraryzlibraryz-librarybetparkmatbetjojobetjojobetholiganbetmatbetlunabetnakitbahiscasibom